INDV | Indivior PharmaceuticalsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$36.28
+$0.91 (+2.57%)

Indivior Pharmaceuticals (INDV) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2024.

Right now the daily is the chart to watch. INDV printed a death cross in Oct 2026, and price has already pulled back to the 200 inside the seven-bar window, so the cross test is open. Price sits above the 50 and the 200 on the daily and between the two on the 4-hour.

Timeframe summary

Daily as of 2 Nov 16:00 ET

Price
above both $36.28 vs 50 $35.18 / 200 $35.68
Projection
No cross projected
Test
Active cross test, 3 bars at the 200, last bar of the window
Last cross
Death cross 22 Oct 2026 ยท projected 20 bars out

Weekly

No weekly data

4-hour as of 2 Nov 16:00 ET

Price
between the two $36.28 vs 50 $35.14 / 200 $37.36
Projection
No cross projected
Test
No active test
Last cross
Death cross 2 Sep 2026 ยท projected 1 bar out

Cross history

5
crosses on record since 2024
2 golden3 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
22 Oct 2026Death moderatedaily20 bars outActive Cross Test
2 Sep 2026Death4-hour1 bar outNot tested
2 Jun 2025Golden moderatedaily23 bars outNot tested
28 May 2024Deathdaily19 bars outNot tested
8 Apr 2024Goldendaily4 bars out5 bar cross test

About INDV

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$68.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2024
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.